Onset and frequency of depression in post-COVID-19 syndrome: A systematic review

O Renaud-Charest, LMW Lui, S Eskander… - Journal of psychiatric …, 2021 - Elsevier
Following recovery from COVID-19, an increasing proportion of individuals have reported
the persistence and/or new onset of symptoms which collectively have been identified as …

Tools and techniques for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)/COVID-19 detection

SH Safiabadi Tali, JJ LeBlanc, Z Sadiq… - Clinical microbiology …, 2021 - Am Soc Microbiol
SUMMARY The coronavirus disease 2019 (COVID-19) pandemic, caused by severe acute
respiratory disease coronavirus 2 (SARS-CoV-2), has led to millions of confirmed cases and …

[HTML][HTML] Severe COVID-19 infection and pediatric comorbidities: a systematic review and meta-analysis

BK Tsankov, JM Allaire, MA Irvine, AA Lopez… - International Journal of …, 2021 - Elsevier
Objective There is limited information on the severity of COVID-19 infection in children with
comorbidities. We investigated the effects of pediatric comorbidities on COVID-19 severity by …

Effect of tocilizumab vs standard care on clinical worsening in patients hospitalized with COVID-19 pneumonia: a randomized clinical trial

C Salvarani, G Dolci, M Massari, DF Merlo… - JAMA internal …, 2021 - jamanetwork.com
Importance The coronavirus disease 2019 (COVID-19) pandemic is threatening billions of
people worldwide. Tocilizumab has shown promising results in retrospective studies in …

Short term, high-dose vitamin D supplementation for COVID-19 disease: a randomised, placebo-controlled, study (SHADE study)

A Rastogi, A Bhansali, N Khare, V Suri… - Postgraduate …, 2022 - academic.oup.com
Background Vitamin D has an immunomodulatory role but the effect of therapeutic vitamin D
supplementation in SARS-CoV-2 infection is not known. Aim Effect of high dose, oral …

Sarilumab in patients admitted to hospital with severe or critical COVID-19: a randomised, double-blind, placebo-controlled, phase 3 trial

FX Lescure, H Honda, RA Fowler, JS Lazar… - The Lancet …, 2021 - thelancet.com
Background Elevated proinflammatory cytokines are associated with greater COVID-19
severity. We aimed to assess safety and efficacy of sarilumab, an interleukin-6 receptor …

Biomarkers in COVID-19: an up-to-date review

M Samprathi, M Jayashree - Frontiers in pediatrics, 2021 - frontiersin.org
The ongoing pandemic of coronavirus disease 2019 (COVID-19) poses several challenges
to clinicians. Timely diagnosis and hospitalization, risk stratification, effective utilization of …

Predictors of in-hospital COVID-19 mortality: A comprehensive systematic review and meta-analysis exploring differences by age, sex and health conditions

AE Mesas, I Cavero-Redondo, C Álvarez-Bueno… - PloS one, 2020 - journals.plos.org
Objective Risk factors for in-hospital mortality in confirmed COVID-19 patients have been
summarized in numerous meta-analyses, but it is still unclear whether they vary according to …

Outcomes of patients with end-stage kidney disease hospitalized with COVID-19

JH Ng, JS Hirsch, R Wanchoo, M Sachdeva… - Kidney international, 2020 - Elsevier
Given the high risk of infection-related mortality, patients with end-stage kidney disease
(ESKD) may be at increased risk with COVID-19. To assess this, we compared outcomes of …

COVID-19 and sex differences: mechanisms and biomarkers

T Haitao, JV Vermunt, J Abeykoon, R Ghamrawi… - Mayo Clinic …, 2020 - Elsevier
Men are consistently overrepresented in severe acute respiratory syndrome coronavirus 2
(SARS-CoV-2) infection, and coronavirus disease 2019 (COVID-19) severe outcomes …